APA (7th ed.) Citation

Lin, E., Garmo, H., Hemelrijck, M. V., Adolfsson, J., Stattin, P., Zethelius, B., & Crawley, D. (2021). Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: A nationwide, population-based cohort study. BMC.

Chicago Style (17th ed.) Citation

Lin, E., Hans Garmo, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin, Björn Zethelius, and Danielle Crawley. Exploring the Association Between Use of Gonadotropin Releasing Hormones Agonists and Prostate Cancer Diagnosis Per Se and Diabetes Control in Men with Type 2 Diabetes Mellitus: A Nationwide, Population-based Cohort Study. BMC, 2021.

MLA (8th ed.) Citation

Lin, E., et al. Exploring the Association Between Use of Gonadotropin Releasing Hormones Agonists and Prostate Cancer Diagnosis Per Se and Diabetes Control in Men with Type 2 Diabetes Mellitus: A Nationwide, Population-based Cohort Study. BMC, 2021.